AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
COMBINATION E2F-1 AND P53 GENE-TRANSFER DOES NOT ENHANCE GROWTH-INHIBITION IN HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: FRANK DK LIU TJ FREDERICK MJ CLAYMAN GL
Citation: Dk. Frank et al., COMBINATION E2F-1 AND P53 GENE-TRANSFER DOES NOT ENHANCE GROWTH-INHIBITION IN HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Clinical cancer research, 4(9), 1998, pp. 2265-2272
BYSTANDER EFFECT IN THE ADENOVIRUS-MEDIATED WILD-TYPE P53 GENE-THERAPY MODEL OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: FRANK DK FREDERICK MJ LIU TJ CLAYMAN GL
Citation: Dk. Frank et al., BYSTANDER EFFECT IN THE ADENOVIRUS-MEDIATED WILD-TYPE P53 GENE-THERAPY MODEL OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Clinical cancer research, 4(10), 1998, pp. 2521-2528
DIFFERENTIAL EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN HEAD AND NECK CANCERS
Authors: KE LD ADLERSTORTHZ K CLAYMAN GL YUNG AWK CHEN Z
Citation: Ld. Ke et al., DIFFERENTIAL EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN HEAD AND NECK CANCERS, Head & neck, 20(4), 1998, pp. 320-327
SURGICAL OUTCOMES IN HEAD AND NECK-CANCER PATIENTS 80 YEARS OF AGE AND OLDER
Authors: CLAYMAN GL EICHER SA SICARD MW RAZMPA E GOEPFERT H
Citation: Gl. Clayman et al., SURGICAL OUTCOMES IN HEAD AND NECK-CANCER PATIENTS 80 YEARS OF AGE AND OLDER, Head & neck, 20(3), 1998, pp. 216-223
PROGNOSTIC SIGNIFICANT OF BIOMARKERS (P21(WAF1 CIP1,) P53, BCL-2) IN LARYNGEAL SQUAMOUS-CELL CARCINOMA/
Authors: JIN YT KAYSER S KEMP BL ORDONEZ NG TUCKER SL GOEPFERT H LUNA MA CLAYMAN GL BATSAKIS JG
Citation: Yt. Jin et al., PROGNOSTIC SIGNIFICANT OF BIOMARKERS (P21(WAF1 CIP1,) P53, BCL-2) IN LARYNGEAL SQUAMOUS-CELL CARCINOMA/, Modern pathology, 11(1), 1998, pp. 120-120
IS SELECTIVE NECK DISSECTION REALLY AS EFFICACIOUS AS MODIFIED RADICAL NECK DISSECTION FOR ELECTIVE TREATMENT OF THE CLINICALLY NEGATIVE NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE UPPER RESPIRATORY AND DIGESTIVE TRACTS - REPLY
Authors: CLAYMAN GL BYERS RM FRANK D
Citation: Gl. Clayman et al., IS SELECTIVE NECK DISSECTION REALLY AS EFFICACIOUS AS MODIFIED RADICAL NECK DISSECTION FOR ELECTIVE TREATMENT OF THE CLINICALLY NEGATIVE NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE UPPER RESPIRATORY AND DIGESTIVE TRACTS - REPLY, Archives of otolaryngology, head & neck surgery, 124(9), 1998, pp. 1044-1044
SELECTIVE NECK DISSECTION OF ANATOMICALLY APPROPRIATE LEVELS IS AS EFFICACIOUS AS MODIFIED RADICAL NECK DISSECTION FOR ELECTIVE TREATMENT OF THE CLINICALLY NEGATIVE NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE UPPER RESPIRATORY AND DIGESTIVE TRACTS
Authors: CLAYMAN GL FRANK DK
Citation: Gl. Clayman et Dk. Frank, SELECTIVE NECK DISSECTION OF ANATOMICALLY APPROPRIATE LEVELS IS AS EFFICACIOUS AS MODIFIED RADICAL NECK DISSECTION FOR ELECTIVE TREATMENT OF THE CLINICALLY NEGATIVE NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE UPPER RESPIRATORY AND DIGESTIVE TRACTS, Archives of otolaryngology, head & neck surgery, 124(3), 1998, pp. 348-352
IN-VITRO GROWTH SUPPRESSION BY ADENOVIRAL TRANSDUCTION OF P21 AND P16IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A RESEARCH MODEL FOR COMBINATION GENE-THERAPY
Authors: MOBLEY SR LIU TJ HUDSON JM CLAYMAN GL
Citation: Sr. Mobley et al., IN-VITRO GROWTH SUPPRESSION BY ADENOVIRAL TRANSDUCTION OF P21 AND P16IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A RESEARCH MODEL FOR COMBINATION GENE-THERAPY, Archives of otolaryngology, head & neck surgery, 124(1), 1998, pp. 88-92
ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: CLAYMAN GL ELNAGGAR AK LIPPMAN SM HENDERSON YC FREDERICK M MERRITT JA ZUMSTEIN LA TIMMONS TM LIU TJ GINSBERG L ROTH JA HONG WK BRUSO P GOEPFERT H
Citation: Gl. Clayman et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(6), 1998, pp. 2221-2232
PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: SHIN DM GLISSON BS KHURI FR GINSBERG L PAPADIMITRAKOPOULOU V LEE JJ LAWHORN K GILLENWATER AM ANG KK CLAYMAN GL CALLENDER DL HONG WK LIPPMAN SM
Citation: Dm. Shin et al., PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
A SIMPLE AND SENSITIVE METHOD FOR DETECTING ADENOVIRUS IN SERUM AND URINE
Authors: HENDERSON YC LIU TJ CLAYMAN GL
Citation: Yc. Henderson et al., A SIMPLE AND SENSITIVE METHOD FOR DETECTING ADENOVIRUS IN SERUM AND URINE, Journal of virological methods, 71(1), 1998, pp. 51-56
GENOTYPIC ANALYSIS OF TUMOR-SUPPRESSOR GENES PTEN MMAC1 AND P53 IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS/
Authors: HENDERSON YC WANG E CLAYMAN GL
Citation: Yc. Henderson et al., GENOTYPIC ANALYSIS OF TUMOR-SUPPRESSOR GENES PTEN MMAC1 AND P53 IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS/, The Laryngoscope, 108(10), 1998, pp. 1553-1556
VARIABLE EXPRESSION OF CYTOKINES IN HUMAN HEAD AND NECK SQUAMOUS-CELLCARCINOMA CELL-LINES AND CONSISTENT EXPRESSION IN SURGICAL SPECIMENS
Authors: WOODS KV ELNAGGAR A CLAYMAN GL GRIMM EA
Citation: Kv. Woods et al., VARIABLE EXPRESSION OF CYTOKINES IN HUMAN HEAD AND NECK SQUAMOUS-CELLCARCINOMA CELL-LINES AND CONSISTENT EXPRESSION IN SURGICAL SPECIMENS, Cancer research, 58(14), 1998, pp. 3132-3141
INTERLEUKIN-1 REGULATES INTERLEUKIN-6 SECRETION IN HUMAN ORAL SQUAMOUS-CELL CARCINOMA IN-VITRO - POSSIBLE INFLUENCE OF P53 BUT NOT HUMAN-PAPILLOMAVIRUS E6 E7/
Authors: WOODS KV ADLERSTORTHZ S CLAYMAN GL FRANCIS GM GRIMM EA
Citation: Kv. Woods et al., INTERLEUKIN-1 REGULATES INTERLEUKIN-6 SECRETION IN HUMAN ORAL SQUAMOUS-CELL CARCINOMA IN-VITRO - POSSIBLE INFLUENCE OF P53 BUT NOT HUMAN-PAPILLOMAVIRUS E6 E7/, Cancer research, 58(14), 1998, pp. 3142-3149
THE PROGNOSTIC-SIGNIFICANCE OF THE BIOMARKERS P21(WAF1 CIP1), P53, AND BCL-2 IN LARYNGEAL SQUAMOUS-CELL CARCINOMA/
Authors: JIN YT KAYSER S KEMP BL ORDONEZ NG TUCKER SL CLAYMAN GL GOEPFERT H LUNA MA BATSAKIS JG ELNAGGAR AK
Citation: Yt. Jin et al., THE PROGNOSTIC-SIGNIFICANCE OF THE BIOMARKERS P21(WAF1 CIP1), P53, AND BCL-2 IN LARYNGEAL SQUAMOUS-CELL CARCINOMA/, Cancer, 82(11), 1998, pp. 2159-2165
ADENOVIRUS-MEDIATED P53 GEAR TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: CLAYMAN GL ELNAGGAR AK LIPPMANN SM HENDERSON YC FREDERICK M LIU TJ GINSBERG L MERRITT J ZUMSTEIN L TIMMONS T ROTH JA HONG WK BRUSO P GOEPFERT H
Citation: Gl. Clayman et al., ADENOVIRUS-MEDIATED P53 GEAR TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, British Journal of Cancer, 77, 1998, pp. 1511-1511
HEAD AND NECK SQUAMOUS-CELL GROWTH SUPPRESSION USING ADENOVIRUS-P53-FLAG - A POTENTIAL MARKER FOR GENE-THERAPY TRIALS
Authors: OVERHOLT SM LIU TJ TAYLOR DL WANG M ELNAGGAR AK SHILLITOE E ADLERSTORTHZ K STJOHN L ZHANG WW ROTH JA CLAYMAN GL
Citation: Sm. Overholt et al., HEAD AND NECK SQUAMOUS-CELL GROWTH SUPPRESSION USING ADENOVIRUS-P53-FLAG - A POTENTIAL MARKER FOR GENE-THERAPY TRIALS, Clinical cancer research, 3(2), 1997, pp. 185-191
STRONG CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND OVERALL SURVIVAL OF PATIENTS WITH ORAL SQUAMOUS-CELL CARCINOMA
Authors: XIA WY LAU YK ZHANG HZ LIU AR LI L KIYOKAWA N CLAYMAN GL KATZ RL HUNG MC
Citation: Wy. Xia et al., STRONG CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND OVERALL SURVIVAL OF PATIENTS WITH ORAL SQUAMOUS-CELL CARCINOMA, Clinical cancer research, 3(1), 1997, pp. 3-9
CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER
Authors: MERRITT JA CLAYMAN GL SWISHER S NEMUNAITIS J ELNAGGAR A GINSBERG L LAWRENCE D TIMMONS T HENDERSON Y FREDERICK M CONNORS D HUTCHISON A BRUSO P ROTH JA SHULKIN A WEILL D WAIT J
Citation: Ja. Merritt et al., CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER, Cancer gene therapy, 4(6), 1997, pp. 1-1
REPORT OF THE 10TH INTERNATIONAL-SYMPOSIUM OF THE FOUNDATION-FOR-PROMOTION-OF-CANCER-RESEARCH - BASIC AND CLINICAL RESEARCH IN HEAD AND NECK-CANCER
Authors: CLAYMAN GL EBIHARA S TERADA M MUKAI K GOEPFERT H
Citation: Gl. Clayman et al., REPORT OF THE 10TH INTERNATIONAL-SYMPOSIUM OF THE FOUNDATION-FOR-PROMOTION-OF-CANCER-RESEARCH - BASIC AND CLINICAL RESEARCH IN HEAD AND NECK-CANCER, Japanese Journal of Clinical Oncology, 27(5), 1997, pp. 361-368
INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA - RESULTS OF AMATCHED COHORT STUDY
Authors: GEARA FB GLISSON BS SANGUINETI G TUCKER SL GARDEN AS ANG KK LIPPMAN SM CLAYMAN GL GOEPFERT H PETERS LJ HONG WK
Citation: Fb. Geara et al., INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA - RESULTS OF AMATCHED COHORT STUDY, Cancer, 79(7), 1997, pp. 1279-1286
EVALUATION OF TOPICAL GENE-THERAPY FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA IN AN ORGANOTYPIC MODEL
Authors: EICHER SA CLAYMAN GL LIU TJ SHILLITOE EJ STORTHZ KA ROTH JA LOTAN R
Citation: Sa. Eicher et al., EVALUATION OF TOPICAL GENE-THERAPY FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA IN AN ORGANOTYPIC MODEL, Clinical cancer research, 2(10), 1996, pp. 1659-1664
EXPRESSION OF GALECTINS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: GILLENWATER A XU XC ELNAGGAR AK CLAYMAN GL LOTAN R
Citation: A. Gillenwater et al., EXPRESSION OF GALECTINS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Head & neck, 18(5), 1996, pp. 422-432
ADENOVIRUS-MEDIATED P16 CDKN2 GENE-TRANSFER INDUCES GROWTH ARREST ANDMODIFIES THE TRANSFORMED PHENOTYPE OF GLIOMA-CELLS/
Authors: FUEYO J GOMEZMANZANO C YUNG WKA CLAYMAN GL LIU TJ BRUNER J LEVIN VA KYRITSIS AP
Citation: J. Fueyo et al., ADENOVIRUS-MEDIATED P16 CDKN2 GENE-TRANSFER INDUCES GROWTH ARREST ANDMODIFIES THE TRANSFORMED PHENOTYPE OF GLIOMA-CELLS/, Oncogene, 12(1), 1996, pp. 103-110
GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/
Authors: CLAYMAN GL LIU TJ OVERHOLT SM MOBLEY SR WANG M JANOT F GOEPFERT H
Citation: Gl. Clayman et al., GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/, Archives of otolaryngology, head & neck surgery, 122(5), 1996, pp. 489-493
Risultati: 1-25 | 26-42